A review of the molecular diagnosis of thalassemia
X Gu, Y Zeng - Hematology, 2002 - Taylor & Francis
The thalassaemias are a major health problem, and approximately 1 in 14 of the population
are carriers for one of the sub types. For the purpose of prevention and control of clinically …
are carriers for one of the sub types. For the purpose of prevention and control of clinically …
[HTML][HTML] Detection of β-globin gene mutations among β-thalassaemia carriers and patients in Malaysia: application of multiplex amplification refractory mutation system …
S Hassan, R Ahmad, Z Zakaria, Z Zulkafli… - … Malaysian journal of …, 2013 - ncbi.nlm.nih.gov
Background: β-thalassaemia is one of the most common single-gene disorders worldwide.
Each ethnic population has its own common mutations, accounting for the majority of cases …
Each ethnic population has its own common mutations, accounting for the majority of cases …
Molecular genetic confirmatory testing from newborn screening samples for the common African‐American, Asian Indian, Southeast Asian, and Chinese β …
U Bhardwaj, YH Zhang, F Lorey… - American journal of …, 2005 - Wiley Online Library
Abstract β‐Thalassemia is a serious health problem in the United States, especially in
California, due to increased Asian immigration. Neonatal screening by using high …
California, due to increased Asian immigration. Neonatal screening by using high …
Multiplex minisequencing screen for common Southeast Asian and Indian β-thalassemia mutations
W Wang, SKY Kham, GH Yeo, TC Quah… - Clinical …, 2003 - academic.oup.com
Background: β-Thalassemia is endemic to many regions in Southeast Asia and India, and<
20 β-globin gene mutations account for≥ 90% of β-thalassemia alleles in these places. We …
20 β-globin gene mutations account for≥ 90% of β-thalassemia alleles in these places. We …
Neonatal hemoglobinopathy screening: molecular genetic technologies
U Bhardwaj, YH Zhang, ERB McCabe - Molecular genetics and metabolism, 2003 - Elsevier
Newborn screening is a systematic application of tests for early detection, diagnosis, and
treatment of certain genetic or metabolic disorders that can lead to mortality, morbidity, and …
treatment of certain genetic or metabolic disorders that can lead to mortality, morbidity, and …
Characterisation and confirmation of rare beta‐thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia
JA Mary Anne Tan, PS Chin, YC Wong, KL Tan… - Pathology, 2006 - Taylor & Francis
Aims: In Malaysia, about 4.5% of the Malay and Chinese populations are heterozygous
carriers of β‐thalassaemia. The initial identification of rare β‐globin gene mutations by …
carriers of β‐thalassaemia. The initial identification of rare β‐globin gene mutations by …
Characterisation of β-globin gene mutations in Malaysian children: A strategy for the control of β-thalassaemia in a developing country
Abstract β-thalassaemia major, an autosomal recessive hemoglobinopathy, is one of the
most common single gene disorders in multi-racial Malaysia. The control of β-thalassaemia …
most common single gene disorders in multi-racial Malaysia. The control of β-thalassaemia …
[HTML][HTML] Molecular characterisation of Haemoglobin constant spring and Haemoglobin Quong Sze with a combine-amplification refractory mutation system
YC Wee, KL Tan, KH Chua, E George… - The Malaysian journal …, 2009 - ncbi.nlm.nih.gov
Background: The interaction of the non-deletional α+-thalassaemia mutations Haemoglobin
Constant Spring and Haemoglobin Quong Sze with the Southeast Asian double α-globin …
Constant Spring and Haemoglobin Quong Sze with the Southeast Asian double α-globin …
Towards a prevention program for β-thalassemia. The molecular spectrum in East Java, Indonesia
PY Hernanda, L Tursilowati, SGJ Arkesteijn… - …, 2012 - Taylor & Francis
Defining the spectrum of specific thalassemia mutations is an important issue when planning
prevention programs in large multi ethnic countries as is Indonesia. In a first attempt to …
prevention programs in large multi ethnic countries as is Indonesia. In a first attempt to …
Determination of SMN1/SMN2 Gene Dosage by a Quantitative Genotyping Platform Combining Capillary Electrophoresis and MALDI-TOF Mass Spectrometry
HY Kao, YN Su, HK Liao, MS Liu, YJ Chen - Clinical chemistry, 2006 - academic.oup.com
Background: Spinal muscular atrophy (SMA) is a common inherited and fatal neuromuscular
disease caused by deletions and/or mutations that lead to altered concentrations of proteins …
disease caused by deletions and/or mutations that lead to altered concentrations of proteins …